EP Patent

EP3753554A1 — Extended-release pharmaceutical composition containing lacosamide

Assigned to Whan In Pharmaceutical Co · Expires 2020-12-23 · 5y expired

What this patent protects

The present invention relates to an extended-release lacosamide preparation which can be taken once a day.

USPTO Abstract

The present invention relates to an extended-release lacosamide preparation which can be taken once a day.

Drugs covered by this patent

Vimpat (lacosamide) · UCB

Patent Metadata

Patent number: EP3753554A1
Jurisdiction: EP
Classification: —
Expires: 2020-12-23
Drug substance claim: No
Drug product claim: No
Assignee: Whan In Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.